The current study demonstrated that CD33 HLA-DR myeloid-derived suppressor cells (MDSCs) were significantly increased in the peripheral blood of patients with T1D and positively correlated with the levels of HbA1C (50). This evidence concerns the gene CD33 and type 1 diabetes mellitus.